Investigation led by Collins uncovers monopoly business model in prescription drug industry
A year-long investigation into abrupt prescription drug price increases led by U.S. Sen. Susan Collins (R-ME) culminated in a report released on Wednesday that found drug companies have used a monopoly business to inflate prices. Collins, the chairman of the Read more…